Latest Alpha 1 antitrypsin
in:
Genetically Modified Organisms
Inspector's Report
Year: 2010
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
GMO Register Entry
Year: 2010
The GMO Register Entry provides significant details of the clinical trial.
Consent Conditions
Year: 2010
Consent Conditions G0362-01 issued to Applied Genetics Technologies Corporation, USA, to carry out a clinical trial on patients suffering from alpha-1 antitrypsin deficiency, using a Genetically Modified Micro-Organism (GMM). This trial did not proceed.